Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 6, 2013, Pages 616-625

  Grigg Damberger, Madeleine ^a,b,c   Ralls, Frank ^b,d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

circadian rhythm; clock genes; insomnia; melatonin; neurodevelopmental disorders

Indexed keywords

ACEBUTOLOL; ARIPIPRAZOLE; ASCORBIC ACID; ATOMOXETINE; CLONAZEPAM; CLONIDINE; FLUOXETINE; GUANFACINE; IRON; MELATONIN; PLACEBO; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; AUTISM; AUTOMUTILATION; BEDTIME DOSAGE; BEHAVIOR DISORDER; BEHAVIOR THERAPY; COGNITIVE THERAPY; DEVELOPMENTAL DISORDER; DISEASE PREDISPOSITION; DROWSINESS; DRUG DOSE INCREASE; EPIGENETICS; FAMILY; GENE CONTROL; GENETIC DISORDER; HAPPY PUPPET SYNDROME; HEALTH EDUCATION; HORMONE BLOOD LEVEL; HUMAN; INSOMNIA; IRON THERAPY; IRRITABILITY; MORNING DOSAGE; NEUROLOGIC DISEASE; RETT SYNDROME; REVIEW; SIDE EFFECT; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SMITH MAGENIS SYNDROME; TREATMENT OUTCOME; WAKEFULNESS; WEIGHT GAIN; WILLIAMS BEUREN SYNDROME;

ANGELMAN SYNDROME; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CHRONIC DISEASE; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MELATONIN; PARENTS; QUALITY OF LIFE; QUESTIONNAIRES; RETT SYNDROME; SLEEP INITIATION AND MAINTENANCE DISORDERS; SMITH-MAGENIS SYNDROME; TREATMENT OUTCOME; WILLIAMS SYNDROME;

EID: 84885190196     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328365ab89     Document Type: Review

References (87)

1. van Steensel FJ, Dirksen CD, Bogels SM. A cost of illness study of children with high-functioning autism spectrum disorders and comorbid anxiety disorders as compared to clinically anxious and typically developing children. J Autism Dev Disord 2013; 43:361-370.
2. Owens JA, Mindell JA. Pediatric insomnia. Pediatr Clin North Am 2011; 58:555-569.
3. Ipsiroglu OS, McKellin WH, Carey N, Loock C. They silently live in terror...' why sleep problems and night-time related quality-of-life are missed in children with a fetal alcohol spectrum disorder. Soc Sci Med 2013; 79:76-83.
4. Goldman SE, Bichell TJ, Surdyka K, Malow BA. Sleep in children and adolescents with Angelman syndrome: association with parent sleep and stress. J Intellect Disabil Res: JIDR 2012; 56:600-608.
5. Rao PA, Beidel DC. The impact of children with high-functioning autism on parental stress, sibling adjustment, and family functioning. Behav Modif 2009; 33:437-451.
6. Bourke-Taylor H, Pallant JF, Law M, Howie L. Relationships between sleep disruptions, health and care responsibilities among mothers of school-aged children with disabilities. J Paediatr Child Health 2013; 49:775-782.
7. Malow BA, Adkins KW, Reynolds A, et al. Parent-based sleep education for children with autism spectrum disorders. J Autism Dev Disord 2013. [Epub ahead of print]
8. Malow BA, Byars K, Johnson K, et al. A practice pathway fo. The identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics 2012; 130 (Suppl 2):S106-S124.
9. Allen KD, Kuhn BR, DeHaai KA, Wallace DP. Evaluation of a behavioral treatment package to reduce sleep problems in children with Angelman syndrome. Res Dev Disabil 2013; 34:676-686.
10. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012; 61:1-19.
11. Zafeiriou DI, Ververi A, Dafoulis V, et al. Autism spectrum disorders. The quest for genetic syndromes. Am J Med Genet B Neuropsychiatr Genet 2013; 162:327-366.
12. Gapp K, Woldemichael BT, Bohacek J, Mansuy IM. Epigenetic regulation in neurodevelopment and neurodegenerative diseases. Neuroscience 2012. [Epub ahead of print]
13. Flashner BM, Russo ME, Boileau JE, et al. Epigenetic factors and autism spectrum disorders. Neuromolecular Med 2013.
14. Ginsberg MR, Rubin RA, Falcone T, et al. Brain transcriptional and epigenetic associations with autism. PLoS One 2012; 7:e44736.
15. Sgado P, Genovesi S, Kalinovsky A, et al. Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: implications for autism spectrum disorders. Exp Neurol 2013; 247:496-505.
16. Sgado P, Dunleavy M, Genovesi S, et al. The role of GABAergic system in neurodevelopmental disorders\: A focus on autism and epilepsy. Int J Physiol Pathophysiol Pharmacol 2011; 3:223-235.
17. Kotagal S, Broomall E. Sleep in children with autism spectrum disorder. Pediatr Neurol 2012; 47:242-251.
18. Tordjman S, Anderson GM, Bellissant E, et al. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology 2012; 37:1990-1997.
19. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders\: A systematic review and meta-analysis. Dev Med Child Neurol 2011; 53:783-792.
20. Leu RM, Beyderman L, Botzolakis EJ, et al. Relation of melatonin to sleep architecture in children with autism. J Autism Dev Disord 2011; 41:427-433.
21. Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
22. Geier DA, Kern JK, Geier MR. A prospective cross-sectional cohort assessment of health, physical, and behavioral problems in autism spectrum disorders. Maedica 2012; 7:193-200.
23. Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, et al. Sleep problems in children with autism spectrum disorders, developmental delays, and typical development\: A population-based study. J Sleep Res 2008; 17: 197-206.
24. Cortesi F, Giannotti F, Ivanenko A, Johnson K. Sleep in children with autistic spectrum disorder. Sleep Med 2010; 11:659-664.
25. Sivertsen B, Posserud MB, Gillberg C, et al. Sleep problems in children with autism spectrum problems\: A longitudinal population-based study. Autism 2012; 16:139-150.
26. Hollway JA, Aman MG, Butter E. Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network. J Autism Dev Disord 2013. [Epub ahead of print]
27. Sikora DM, Johnson K, Clemons T, Katz T. The relationship between sleep problems and daytime behavior in children of different ages with autism spectrum disorders. Pediatrics 2012; 130 (Suppl 2):S83-S90.
28. Taylor MA, Schreck KA, Mulick JA. Sleep disruption as a correlate to cognitive and adaptive behavior problems in autism spectrum disorders. Res Dev Disabil 2012; 33:1408-1417.
29. Buckley AW, Rodriguez AJ, Jennison K, et al. Rapid eye movement sleep percentage in children with autism compared with children with developmental delay and typical development. Arch Pediatr Adolesc Med 2010; 164:1032-1037.
30. Malow B, Adkins KW, McGrew SG, et al. Melatonin for sleep in children with autism\: A controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord 2012; 42:1729-1737; author reply 38.
31. Wright B, Sims D, Smart S, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies\: A randomised controlled crossover trial. J Autism Dev Disord 2010; 41:175-184.
32. Wirojanan J, Jacquemont S, Diaz R, et al. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med 2009; 5:145-150.
33. Gringras P, Gamble C, Jones AP, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ 2012; 345:e6664.
34. Ming X, Gordon E, Kang N, Wagner GC. Use of clonidine in children with autism spectrum disorders. Brain Dev 2008; 30:454-460.
35. Fankhauser MP, Karumanchi VC, German ML, et al. A double-blind, placebocontrolled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1992; 53:77-82.
36. Handen BL, Sahl R, Hardan AY. Guanfacine in children with autism and/or intellectual disabilities. J Dev Behav Pediatr 2008; 29:303-308.
37. Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 2006; 45:1196-1205.
38. Koshes RJ, Rock NL. Use of clonidine for behavioral control in an adult patient with autism. Am J Psychiatry 1994; 151:1714.
39. Hollander E, Soorya L, Wasserman S, et al. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol 2006; 9:209-213.
40. Anagnostou E, Esposito K, Soorya L, et al. Divalproex versus placebo fo. The prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. J Clin Psychopharmacol 2006; 26:444-446.
41. Hollander E, Phillips A, Chaplin W, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 2005; 30:582-589.
42. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009; 48:1110-1119.
43. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009; 124: 1533-1540.
44. Lemmon ME, Gregas M, Jeste SS. Risperidone use in autism spectrum disorders\: A retrospective review of a clinic-referred patient population. J Child Neurol 2011; 26:428-432.
45. Brachlow AE, Ness KK, McPheeters ML, Gurney JG. Comparison of indicators for a primary care medical home between children with autism or asthma and other special healthcare needs: National Survey of Children's Health. Arch Pediatr Adolesc Med 2007; 161:399-405.
46. Bitterman A, Daley TC, Misra S, et al. A national sample of preschoolers with autism spectrum disorders: special education services and parent satisfaction. J Autism Dev Disord 2008; 38:1509-1517.
47. Carbone PS, Farley M, Davis T. Primary care for children with autism. Am Fam Physician 2010; 81:453-460.
48. Christodoulou J, Ho G. MECP2-related disorders. 3 October 2001 [Updated 28 June 2012]. In: Pagon RA, Adam MP, Bird TD, et al., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013. http://www.ncbi.nlm.nih.gov/books/NBK1497/.
49. Laurvick CL, de Klerk N, Bower C, et al. Rett syndrome in Australia\: A review of the epidemiology. J Pediatr 2006; 148:347-352.
50. Marschik PB, Kaufmann WE, Sigafoos J, et al. Changin. The perspective on early development of Rett syndrome. Res Dev Disabil 2013; 34:1236-1239.
51. Bahi-Buisson N. Genetically determined encephalopathy: Rett syndrome. Handb Clin Neurol 2013; 111:281-286.
52. Ren J, Ding X, Funk GD, Greer JJ. Anxiety-related mechanisms of respiratory dysfunction in a mouse model of Rett syndrome. J Neurosc 2012; 32:17230-17240.
53. Julu PO, Witt Engerstrom I, Hansen S, Apartopoulos F. Engerstrom B, group E. Treating hypoxia in a feeble breather with Rett syndrome. Brain Dev 2013; 35:270-273.
54. Smeets EE, Julu PO, van Waardenburg D, et al. Management of a severe forceful breather with Rett syndrome using carbogen. Brain Dev 2006; 28:625-632.
55. Young D, Nagarajan L, de Klerk N, et al. Sleep problems in Rett syndrome. Brain Dev 2007; 29:609-616.
56. Ellaway C, Peat J, Leonard H, Christodoulou J. Sleep dysfunction in Rett syndrome: lack of age related decrease in sleep duration. Brain Dev 2001; 23 (Suppl 1):S101-S103.
57. Carotenuto M, Esposito M, D'Aniello A, et al. Polysomnographic findings in Rett syndrome\: A case-control study. Sleep Breath 2013; 17:93-98.
58. Hagebeuk EE, van den Bossche RA, de Weerd AW. Respiratory and sleep disorders in female children with atypical Rett syndrome caused by mutations in the CDKL5 gene. Dev Med Child Neurol 2013; 55:480-484.
59. d'Orsi G, Trivisano M, Luisi C, et al. Epileptic seizures, movement disorders, and breathing disturbances in Rett syndrome: diagnostic relevance of videopolygraphy. Epilepsy Behav 2012; 25:401-407.
60. Weese-Mayer DE, Lieske SP, Boothby CM, et al. Autonomic dysregulation in young girls with Rett syndrome during nighttime in-home recordings. Pediatr Pulmonol 2008; 43:1045-1060.
61. Rohdin M, Fernell E, Eriksson M, et al. Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol 2007; 37:338-344.
62. Dolce A, Ben-Zeev B, Naidu S, Kossoff EH. Rett syndrome and epilepsy: an update for child neurologists. Pediatr Neurol 2013; 48:337-345.
63. McArthur AJ, Budden SS. Sleep dysfunction in Rett syndrome\: A trial of exogenous melatonin treatment. Dev Med Child Neurol 1998; 40:186-192.
64. Dagli AIWC. Angelman syndrome. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 2011.
65. Thibert RL, Larson AM, Hsieh DT, et al. Neurologic manifestations of angelman syndrome. Pediatr Neurol 2013; 48:271-279.
66. Kyllerman M. Angelman syndrome. Handb Clin Neurol 2013; 111:287-290.
67. Pelc K, Cheron G, Boyd SG, Dan B. Are there distinctive sleep problems in Angelman syndrome? Sleep Med 2008; 9:434-441.
68. Bruni O, Ferri R, D'Agostino G, et al. Sleep disturbances in Angelman syndrome\: A questionnaire study. Brain Dev 2004; 26:233-240.
69. Conant KD, Thibert RL, Thiele EA. Epilepsy and the sleep-wake patterns found in Angelman syndrome. Epilepsia 2009; 50:2497-2500.
70. Didden R, Korzilius H, Smits MG, Curfs LM. Sleep problems in individuals with Angelman syndrome. Am J Ment Retard 2004; 109:275-284.
71. Walz NC, Beebe D, Byars K. Sleep in individuals with Angelman syndrome: parent perceptions of patterns and problems. Am J Ment Retard 2005; 110:243-252.
72. Takaesu Y, Komada Y, Inoue Y. Melatonin profile and its relation to circadian rhythm sleep disorders in Angelman syndrome patients. Sleep Med 2012; 13:1164-1170.
73. Braam W, Didden R, Smits MG, Curfs LM. Melatonin for chronic insomnia in Angelman syndrome\: A randomized placebo-controlled trial. J Child Neurol 2008; 23:649-654.
74. De Leersnyder H. Smith-Magenis syndrome. Handb Clin Neurol 2013; 111:295-296.
75. Smith ACM, Boyd KE, Elsea SH, et al. Smith-Magenis syndrome. 22 October 2001 [Updated 28 June 2012]. In: Pagon RA, Adam MP, Bird TD, et al., editors. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2013. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1310/.
76. Williams SR, Zies D, Mullegama SV, et al. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 2012; 90:941-949.
77. Novakova M, Nevsimalova S, Prihodova I, et al. Alteration of the circadian clock in children with Smith-Magenis syndrome. J Clin Endocrinol Metab 2012; 97:E312-E318.
78. De Leersnyder H, de Blois MC, Vekemans M, et al. Beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J Med Genet 2001; 38:586-590.
79. De Leersnyder H, de Blois MC, Bresson JL, et al. Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome. Rev Neurol (Paris) 2003; 159 (11 Suppl):6S21-6S26.
80. Carpizo R, Martinez A, Mediavilla D, et al. Smith-Magenis syndrome\: A case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. J Pediatr 2006; 149:409-411.
81. Laje G, Bernert R, Morse R, et al. Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome. Am J Med Genet C Semin Med Genet 2010; 154C:463-468.
82. De Leersnyder H. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment. Trends Endocrinol Metab 2006; 17:291-298.
83. Morris CA. Williams syndrome. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews. http://www.ncbi.nlm.nih.gov/books/ NBK1249/. Seattle, WA: University of Washington, Seattle; Updated 13 June 2013.
84. Morris CA. The behavioral phenotype of Williams syndrome\: A recognizable pattern of neurodevelopment. Am J Med Genet C Semin Med Genet 2010; 154C:427-431.
85. Annaz D, Hill CM, Ashworth A, et al. Characterisation of sleep problems in children with Williams syndrome. Res Dev Disabil 2011; 32:164-169.
86. Ashworth A, Hill CM, Karmiloff-Smith A, Dimitriou D. Cross syndrome comparison of sleep problems in children with Down syndrome and Williams syndrome. Res Dev Disabil 2013; 34:1572-1580.
87. Mason TB, Arens R, Sharman J, et al. Sleep in children with Williams syndrome. Sleep Med 2011; 12:892-897.